PET Biomarker Surpasses Traditional Risk Scores in Predicting Survival Outcomes for Large B-Cell Lymphoma Patients
In a groundbreaking advancement for the treatment of large B-cell lymphoma (LBCL), researchers have demonstrated that metabolic tumor volume (MTV), ...
